Cancers, Free Full-Text
Descrição
Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.
Science and health for all children with cancer
PDF) Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: A single center experience
I Am Cancer Free! - Cancer Free Gift - Tapestry
Frontiers Hypoxia-Modified Cancer Cell Metabolism
Home Page: Lung Cancer
100% Cancer Free sticker — Perch Handmade
Cancers, Free Full-Text
Cancer Support Community
from Flow Cytometry to Cytomics, Page 2
Hallmarks of Cancer: The Next Generation: Cell
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
Noninvasive detection of any-stage cancer using free glycosaminoglycans
PDF) Predictors of recurrence free survival for patients with stage II and III colon cancer
Pathology Outlines - Carcinoma-general
de
por adulto (o preço varia de acordo com o tamanho do grupo)
